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Case Report 
 
A 47 year old nulligravid female 
presented to a local hospital with 
chest pain and shortness of breath.  
Her history was also significant for 
menorrhagia and irregular menses of 
approximately 15 years duration.  At 
the outside facility, computed 
tomography (CT) of the chest 
confirmed pulmonary embolism, and 
endometrial biopsy performed 
showed grade 1 endometrioid 
adenocarcinoma with squamous 
differentiation.  She was transferred 
to our hospital at that time.  Her 
medical history is significant for 
morbid obesity with a body mass 
index (BMI) 75, type 2 diabetes, 
obstructive sleep apnea, obstructive 
pulmonary disease and unprovoked 
deep vein thrombosis (DVT) for 
which she was anticoagulated for 5 
years prior to presentation.  During 
her 3 day hospitalization, CT scan 
performed demonstrated pelvic, 
retroperitoneal, inguinal and right 
axillary lymphadenopathy, and 
hepatomegaly with grossly 
unremarkable uterus and ovaries.  
Due to the burden of disease, 
axillary and inguinal lymph node 
biopsy was attempted, however due 
to depth of nodes, the tissue was not 
reached and biopsy efforts were 
abandoned.  Due to poor 
performance status and medical 
comorbidities, she was referred to 
radiation oncology and plans were 
made to complete 45 gray pelvic 
radiation therapy for palliation.   
 
She presented 5 weeks later with 
recurrent chest pain and shortness 
of breath.  Spiral CT of the chest 
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demonstrated numerous lesions that 
were not identified on the prior CT, 
which were concerning for metastatic 
disease.  Again, she was ruled out 
for cardiac cause of disease as well 
as pulmonary embolism.  The 
degree of lymphadenopathy had 
worsened in the subsequent 5 weeks 
as well (as she was not treated 
systemically).  Due to the 
discordance between endometrial 
biopsy and clinical presentation, 
biopsy was attempted.  
Interventional radiology was 
consulted, but was not able to 
perform CT guided biopsy due to the 
patient’s size, as they were unable to 
manipulate the needle while 
performing CT guidance.  Ultrasound 
guided biopsy was attempted (as the 
inguinal and axillary 
lymphadenopathy had worsened), 
but only reactive tissue returned 
which broadened the differential.  
Pulmonology was consulted and did 
not believe the peripheral lesions 
were amenable to biopsy, however 
there was a subcarinal lymph node 
that could be biopsied under general 
anesthesia in the main operating 
room.  Ultrasound performed 
showed no evidence of liver 
metastases, however exam was 
limited by body habitus.  GI was 
consulted to attempt to 
endoscopically biopsy the lymph 
nodes.  They were able to aspirate 
the lymph node on hospital day #4, 
with the results read as metastatic 
adenocarcinoma.  Additionally 
aspiration of an identified liver lesion 
at time of endoscopy was performed, 
and showed adenocarcinoma.   The 
original endometrial tissue was 
stained and was ER/PR positive with 
greater than 50% staining noted.  
The aspirated lymph node material 
staining was notable for CK7 
positivity, but negative for CK20, 
WT-1, TTF-1 and ER/PR.  She was 
discharged after 5 days in the 
hospital. 
 
She again presented 1 week later 
with chest pain and dyspnea.  CT to 
evaluate for pulmonary embolism 
(PE) demonstrated pulmonary 
nodules that had increased in size in 
the 13 day interval.  No pulmonary 
embolism was detected and no 
evidence of cardiac disease was 
noted.  
 
Ultimately within the month, the 
patient elected to go into hospice, 
after worsening metastatic disease.  
Pelvic radiation therapy improved 
her menorrhagia.  She shortly 
thereafter succumbed to her 
disease. 
 
Discussion 
 
The above case demonstrated to the 
hospital team the complexity that 
morbid obesity adds to treating 
patients with all cancers.  Our team 
encountered numerous difficulties in 
obtaining biopsies for diagnosis.  We 
often utilize interventional radiology 
for CT-guided biopsy of lesions that 
are suspicious prior to treatment 
planning, to assess burden of 
disease, or to confirm diagnosis 
when the clinical picture does not 
match the prior biopsy.  Our 
suspicion in her case was elevated 
for a neuroendocrine component, 
mixed mullerian tumor, or dual 
primary.   Thus to confirm a 
diagnosis, additional tissue had to be 
obtained from an endoscopic biopsy. 
Proceedings in Obstetrics and Gynecology, 2011 July; 2(1):15  
Diagnosis of endometrial cancer with morbid obesity     3  
There is little published regarding the 
diagnostic difficulties morbid obesity 
places on patients and physicians 
alike.  The physical exam is often 
more difficult and less reliable for 
positive or negative findings.1 It is 
well known that increased BMI is 
associated with increased all-cause 
mortality.2   Morris et al3 found that 
outer appearances of obesity did not 
correlate with poor outcomes for 
major upper abdominal operations, 
however a simple measurement of 
perinephric fat (as a surrogate for 
intra-abdominal fat) gave a more 
useful risk assessment. 
 
According to the American College 
of Radiology4 imaging is limited by 
obesity.  For computed tomography, 
limits are due to gantry diameter (90 
cm in newer units) and table capacity 
(680 lbs in newer units – both of 
which have been improving in recent 
years).  Magnetic resonance tends to 
be more limited than CT (newer units 
with 70 cm bore and 550 lb 
capacity).  Ultrasound tends to be 
the most affected by obesity at a 
weight of approximately 250 lbs, 
however distribution is important, as 
excessive subcutaneous fat yields 
poor image quality due to attenuation 
of beams prior to reaching 
intraperitoneal structures (versus 
larger amount of intraperitoneal fat 
with less subcutaneous fat).  
Fluoroscopy is limited by the tight 
aperture of 45 cm and table capacity 
of 350 lbs.  
 
When adding imaging-guided biopsy 
of these patients, the difficulties are 
compounded.  For example, in our 
patient, she was able to fit into the 
CT scanner (albeit tightly) however 
the interventional radiologist was not 
able to biopsy during the CT 
guidance as the needle required to 
biopsy the lesion was long, and 
could not be maneuvered adequately 
to obtain tissue for diagnosis.  An 
option that was considered but not 
pursued was the veterinary CT scan, 
which can accommodate a larger 
habitus.  The ultrasound quality was 
severely limited, and biopsy attempts 
only returned reactive tissues, even 
though the lymphadenopathy was 
palpable.  A video-assisted 
thoracoscopic surgery procedure 
was considered to remove a 
peripheral lung lesion, however due 
to the worsening pulmonary 
complications, this was abandoned 
to proceed with endoscopic biopsy.   
 
It required a great deal of discussion 
with the radiology department to 
decide which lesion would be least 
morbid to biopsy.  After failed 
attempts at several methods, the 
gastroenterologist consulted felt the 
retroperitoneal lymphadenopathy 
adjacent to the duodenum was a 
possibility.  The sample was sparse, 
but confirmed a metastatic 
adenocarcinoma and ruled out an 
inflammatory or granulomatous 
process.   
 
It is well known that increasing body 
mass index is associated with 
endometrial cancer, both incidence 
and prognosis.  Numerous cohort 
studies have found associations with 
elevations of BMI and endometrial 
cancer risk.  The Million Women 
Study authors noted a relative risk 
per 10 units BMI of 2.89.5   
Additionally, a large systematic 
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review in 2008 noted a relative risk 
per 5 units BMI of 1.59.6   
 
Not only does the incidence of 
endometrial cancer increase, but the 
all-cause mortality is elevated.  In a 
large cohort registry from the 
American Cancer Society, the 
authors found that the relative risk 
from death due to cancer in the 
uterine corpus is greatly increased 
with BMI 35-39.9 (RR 2.7) and BMI ≥ 
40 (RR 6.25).7  The uterine corpus 
was the body site most affected by 
BMI.   
 
It has not yet been elucidated as to 
whether obesity is a risk factor for 
death from endometrial cancer (as 
most studies support increased risk 
for all-cause mortality, not cancer-
related), or cancer recurrence.  A 
retrospective review in 2006 failed to 
demonstrate a relationship between 
morbid obesity and endometrial 
cancer recurrence.  Other literature 
supports obesity as a risk factor in 
breast, colon and prostate cancer 
recurrence.8  
 
It is estimated by the WHO that in 
2015, 700 million adults will be 
obese.  Physicians generally have 
negative attitudes towards obese 
patients.  In previous surveys, 50% 
of physicians viewed obese patients 
as “awkward, unattractive, ugly, and 
noncompliant”, while 72% of 
physicians felt poorly prepared to 
manage obesity in general.9 The lack 
of preparation likely begins in 
medical school and in most cases, 
lasts the career of the physician. 
 
 
 
Conclusion 
 
Ultimately, this unfortunate woman’s 
obesity caused her to have a worse 
outcome, not only due to medical 
comorbidities, but also with regards 
to delayed diagnosis and treatment 
and progression of disease.  As the 
obesity epidemic worsens, this is 
likely to occur more commonly.  It is 
important to realize the limitations of 
our consults as all aspects and fields 
of medicine are limited by morbid 
obesity.  It is a strong working 
relationship with other providers that 
allowed us to eventually find an 
answer. 
 
 
References 
 
1. Silk AW, McTigue KM. 
Reexamining the physical 
examination for obese patients. 
JAMA. 2011 Jan 12;305(2):193-4. 
Epub 2010 Dec 29. 
 
2. Berrington de Gonzalez A, Hartge 
P, Cerhan JR, Flint AJ, Hannan L, 
MacInnis RJ, Moore SC, Tobias GS, 
Anton-Culver H, Freeman LB, 
Beeson WL, Clipp SL, English DR, 
Folsom AR, Freedman DM, Giles G, 
Hakansson N, Henderson KD, 
Hoffman-Bolton J, Hoppin JA, 
Koenig KL, Lee IM, Linet MS, Park 
Y, Pocobelli G, Schatzkin A, Sesso 
HD, Weiderpass E, Willcox BJ, Wolk 
A, Zeleniuch-Jacquotte A, Willett 
WC, Thun MJ. Body-mass index 
and mortality among 1.46 million 
white adults. N Engl J Med. 2010 
Dec 2;363(23):2211-9. 
 
3. Schreiner MA, Fennerty MB. 
Endoscopy in the obese patient. 
Gastroenterol Clin North Am. 2010 
Mar;39(1):87-97. 
 
 
 
Proceedings in Obstetrics and Gynecology, 2011 July; 2(1):15  
Diagnosis of endometrial cancer with morbid obesity     5  
4. ACR website: Radiology’s big 
challenge: imaging the “morbidly 
obese” 
http://www.acr.org/SecondaryMainM
enuCategories/NewsPublications/Fe
aturedCategories/CurrentHealthCar
eNews/More/ImagingtheMorbidlyOb
ese.aspx 
  
5. Reeves GK, Pirie K, Beral V, 
Green J, Spencer E, Bull D; Million 
Women Study Collaboration. 
Cancer incidence and mortality in 
relation to body mass index in the 
Million Women Study: cohort study. 
BMJ. 2007 Dec 1;335(7630):1134. 
Epub 2007 Nov 6. 
 
6. Renehan AG, Tyson M, Egger M, 
Heller RF, Zwahlen M. Body-mass 
index and incidence of cancer: a 
systematic review and meta-
analysis of prospective 
observational studies. Lancet. 2008 
Feb 16;371(9612):569-78. 
 
7. Calle EE, Rodriguez C, Walker-
Thurmond K, Thun MJ. Overweight, 
obesity, and mortality from cancer in 
a prospectively studied cohort of 
U.S. adults. N Engl J Med. 2003 Apr 
24;348(17):1625-38. 
 
8. von Gruenigen VE, Tian C, 
Frasure H, Waggoner S, Keys H, 
Barakat RR. Treatment effects, 
disease recurrence, and survival in 
obese women with early 
endometrial carcinoma : a 
Gynecologic Oncology Group study. 
Cancer. 2006 Dec 15;107(12):2786-
91. 
 
9. Hall JI. Obesity - a reluctance to 
treat? Obes Facts. 2010;3(2):79-80. 
Epub 2010 Apr 16. 
 
 
 
 
  
